Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 6 Prostatic Neoplasms 2 Solid Tumors 1 Polycystic Ovary Syndrome 1 Pediatric Brain Tumor 1 Lung Neoplasms 1 Inflammation 1 Hyperinsulinism 1 Heart Failure 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Cardiotoxicity 1 Adenocarcinoma of Lung 1

Interventions

Tirzepatide 2 Surveys and Questionnaires 2 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 saxagliptin 1 epalrestat 1 donafenib 1 dapagliflozin 1 Urine Specimen Collection 1 Standard of Care 1 Specimen Handling 1 Phlebotomy 1 Patient Navigation 1 Methods 1 Interviews as Topic 1 Educational Status 1 Early Intervention, Educational 1 Blood Specimen Collection 1 Biopsy 1 Behavior Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus × dapagliflozin × 1 year × Clear all

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡